3[3]Chiu CJ,McArdle AH,Brown R,et al.Intestinal mucosal lesion in low-flow state.Arch-Surg,1970,101:478-483.
4[4]Johnson PC,Sheppeck RA,Hribar SR,et al.Inhibition of platelet retention on artificial microvascular grafts with monoclonal antibodies and a high-affinity peptide directed against platelet membrane glycoproteins.Arterioscler Thromb,1991,11:552-560.
5[5]Hsu-Lin S-C,Berman CL,Furie BC,et al.A platelet membrane protein expressed during platelet activation and secretion.Studies using a monoclonal antibody specific for thrombin-activated platelets.J-Biol-Chem,1984,259:9121-9126.
6[6]Kurokawa T,Takagi H.Mechanism and Prevention of Ischemia-Reperfusion Injury.Transplant-Proc,1999,31:1775-1776.
7[7]Gupta SD,Burroughs AK,Rull R,et al.L-arginine minimizes reperfusion injury in a low-flow,reflow model of liver perfusion.Hepatology,1996,24:163-168.
8[8]Peralta C,Hotter G,Closa D,et al.The protective Role of Adenosine in inducing Nitric Oxide Synthesis in Rat Liver.Hepatology,1999,29:126-131.
8Liu DL, Jeppsson B, Hakansson CH, Odselius R.Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg 1996,131:442-447.
9Dawson TM, Bredt DS, Fotuhi M, Hwang PM,Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 1991, 88:7797-7801.
10Guslandi M. Nitric oxide: an ubiquitous actor in the gastrointestinal tract. Dig Dis 1994, 12:28-36.
